Potassium channel antibody-associated encephalopathy presenting with a frontotemporal dementia-like syndrome

Archives of Neurology

Volumn 64, Issue 10, 2007, Pages 1528-1530

  McKeon, Andrew ^a,b   Marnane, Michael ^a   O'Connell, Martin ^a   Stack, John P ^a   Kelly, Peter J ^a   Lynch, Timothy ^a  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POTASSIUM CHANNEL ANTIBODY; PROTEIN ANTIBODY; STEROID; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL;

AGED; ANAMNESIS; ARTICLE; BRAIN DISEASE; BRAIN METABOLISM; CASE REPORT; CLINICAL EXAMINATION; CLINICAL FEATURE; FRONTOTEMPORAL DEMENTIA; HUMAN; LABORATORY TEST; MALE; NEUROIMAGING; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYNDROME;

AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS; AUTOANTIBODIES; BRAIN DAMAGE, CHRONIC; DEMENTIA; DIAGNOSIS, DIFFERENTIAL; FLUORODEOXYGLUCOSE F18; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEURONS; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; POTASSIUM CHANNELS, VOLTAGE-GATED; PREDNISOLONE; RADIOPHARMACEUTICALS;

EID: 35348906183     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.64.10.1528     Document Type: Article

References (14)

1. Vernino S, Lennon VA. Ion channel and striational antibodies define a continuum of autoimmune neuromuscular hyperexcitability. Muscle Nerve. 2002;26(5):702-707.
2. Hart IK, Maddison P, Newsom-Davis J, Vincent A, Mills KR. Phenotypic variants of autoimmune peripheral nerve hyperexcitability. Brain. 2002;125(pt 8):1887-1895.
3. Vincent A, Buckley C, Schott JM, et al. Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain. 2004;127(pt 3):701-712.
4. Thieben MJ, Lennon VA, Boeve BF, Aksamit AJ, Keegan M, Vernino S. Potentially reversible autoimmune limbic encephalitis with neuronal potassium channel antibody. Neurology. 2004;62(7):1177-1182.
5. Pozo-Rosich P, Clover L, Saiz A, Vincent A, Graus F. Voltage-gated potassium channel antibodies in limbic encephalitis. Ann Neurol. 2003;54(4):530-533.
6. Liguori R, Vincent A, Clover L, et al. Morvan's syndrome: peripheral and central nervous system and cardiac involvement with antibodies to voltage-gated potassium channels. Brain. 2001;124(pt 12):2417-2426.
7. Iranzo A, Graus F, Clover L, et al. Rapid eye movement sleep behavior disorder and potassium channel antibody-associated limbic encephalitis. Ann Neurol. 2006;59(1):178-181.
8. McKnight K, Jiang Y, Hart Y, et al. Serum antibodies in epilepsy and seizure-associated disorders. Neurology. 2005;65(11):1730-1736.
9. Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546-1554.
10. Dubois B, Slachevsky A, Litvan I, Pillon B. The FAB: a Frontal Assessment Battery at bedside. Neurology. 2000;55(11):1621-1626.
11. Miller BL, Diehl J, Freedman M, Kertesz A, Mendez M, Rascovsky K. International approaches to frontotemporal dementia diagnosis: from social cognition to neuropsychology. Ann Neurol. 2003;54(suppl 5):S7-S10.
12. Nyatsanza S, Shetty T, Gregory C, Lough S, Dawson K, Hodges JR. A study of stereotypic behaviours in Alzheimer's disease and frontal and temporal variant frontotemporal dementia. J Neurol Neurosurg Psychiatry. 2003;74(10):1398-1402.
13. Bataller L, Kleopa KA, Wu GF, Rossi JE, Rosenfeld MR, Dalmau J. Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes. J Neurol Neurosurg Psychiatry. 2007;78(4):381-385.
14. Fauser S, Talazko J, Wagner K, et al. FDG-PET and MRI in potassium channel antibody-associated non-paraneoplastic limbic encephalitis: correlation with clinical course and neuropsychology. Acta Neurol Scand. 2005;111(5):338-343.